Jiangsu Hengrui Medicine Co., Ltd. (HKG:1276)
Hong Kong · Delayed Price · Currency is HKD 88.80
+4.00 (4.72%)
At close: Sep 30, 2025
Jiangsu Hengrui Medicine Market Cap
Jiangsu Hengrui Medicine has a market cap or net worth of 521.08 billion as of September 30, 2025. Its market cap has increased by 67.86% in one year.
Market Cap
521.08B
Enterprise Value
482.20B
Revenue
33.03B
Ranking
n/a
PE Ratio
64.66
Stock Price
88.80
Market Cap Chart
Since October 20, 2000, Jiangsu Hengrui Medicine's market cap has increased from 2.43B to 521.08B, an increase of 21,369.49%. That is a compound annual growth rate of 24.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 521.08B | 67.77% |
| Dec 31, 2024 | 310.59B | -1.97% |
| Dec 29, 2023 | 316.84B | 14.05% |
| Dec 30, 2022 | 277.81B | -29.95% |
| Dec 31, 2021 | 396.57B | -43.57% |
| Dec 31, 2020 | 702.75B | 62.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 214.55B |
| JD Health International | 206.50B |
| WuXi Biologics | 160.93B |
| Innovent Biologics | 160.31B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 124.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |